XML 8 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 1,370,456 $ 1,512,883
Accounts receivable, less allowance for credit loss of $6,382 at March 31, 2024 and $6,550 at December 31, 2023 1,572,356 1,532,599
Deferred contract costs 277,771 218,807
Other 153,111 170,907
Total current assets 3,373,694 3,435,196
Property and equipment, less accumulated depreciation and amortization of $604,458 at March 31, 2024 and $597,473 at December 31, 2023 470,055 479,225
Operating lease right-of-use assets 551,682 516,280
Goodwill 7,927 7,927
Deferred federal and state income taxes, net 64,408 63,690
Other assets, net 20,502 21,491
Total assets 4,488,268 4,523,809
Current Liabilities:    
Accounts payable 927,129 860,856
Accrued liabilities, primarily salaries and related costs 433,599 447,336
Contract liabilities 344,552 280,909
Current portion of operating lease liabilities 100,673 99,749
Federal, state and foreign income taxes 20,388 15,562
Total current liabilities 1,826,341 1,704,412
Noncurrent portion of operating lease liabilities 464,262 427,984
Commitments and contingencies
Shareholders’ Equity:    
Preferred stock, none issued 0 0
Common stock, par value $0.01 per share. Issued and outstanding: 141,119 shares at March 31, 2024 and 143,866 shares at December 31, 2023 1,411 1,439
Additional paid-in capital 0 0
Retained earnings 2,401,525 2,580,968
Accumulated other comprehensive loss (207,474) (192,057)
Total shareholders’ equity 2,195,462 2,390,350
Noncontrolling interest 2,203 1,063
Total equity 2,197,665 2,391,413
Total liabilities and equity $ 4,488,268 $ 4,523,809